[35th Congress of the American Society of Clinical Oncology, Atlanta, USA, 15-18 May 1999. Neoplasms of the ovary and gastrointestinal system].
Del Monte
G
G
Divisione di Oncologia Medica II, Istituto Regina Elena, Roma, Italia.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000401:mortality / Q000628:therapy; D003131:Combined Modality Therapy; D003627:Data Interpretation, Statistical; D004067:Digestive System Neoplasms / Q000628:therapy*; D004938:Esophageal Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy; D005260:Female; D005743:Gastrectomy; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009154:Mutation; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy; D013997:Time Factors